US EditionBayer Agrees to US$7.25 Billion Proposed Settlement over Thousands of Roundup Cancer Lawsuits
Bayer aims to limit liability with a $7.25 billion fund over 21 years for about 65,000 claimants alleging Roundup caused non-Hodgkin lymphoma.
- On Feb 19, 2026, Bayer filed a $7.25 billion settlement proposal in St. Louis Circuit Court in Missouri to pay about 65,000 people over 21 years, pending court approval.
- Facing mounting legal costs, Bayer warned these threaten its ability to sell Roundup in U.S. agricultural markets after paying $10 billion and setting aside another $10 billion, following a previous settlement attempt six years ago.
- Payouts would vary based on use and age, with agricultural, industrial or turf workers diagnosed younger than 60 averaging $165,000, residential users aged 60–77 averaging $20,000, and those 78 or older $10,000.
- The proposed settlement would cover future claims and cap Bayer’s liability while assuring payments to current and future plaintiffs; Bayer retains the right to cancel if the opt-outs threshold is exceeded, though it remains unspecified.
- On Friday, February 20, 2026, about 200,000 Roundup-related claims exist, with over 40,000 active lawsuits, and jury verdicts include 13 for Bayer and 11 for plaintiffs.
11 Articles
11 Articles
Pharmaceutical giant Bayer agrees to $7.3 billion payout to settle Roundup weedkiller lawsuits: 'An important milestone'
Bayer agreed to pay $7.25 billion to resolve thousands of claims alleging its herbicide Roundup led to non-Hodgkin's lymphoma, The New York Times reported. What's happening? The German pharmaceutical company submitted the proposed deal to a St. Louis, Missouri, courtroom Feb. 17. It covers claims already filed and those yet to come, with Bayer paying into a fund for 17-21 years. This isn't Bayer's first attempt to end these lawsuits. An earlier …
Bayer proposes $7.25 billion Roundup cancer settlement
Bayer has announced a proposed $7.25 billion class action settlement to address tens of thousands of U.S. lawsuits claiming its Roundup weedkiller caused cancer — including future cases. The deal must still be approved by the court and ties into a key Supreme Court fight over weedkiller warnings. Editor-in-chief Carey Gillam explains. Read more: Bayer proposes $7.25 billion class action settlement in Roundup litigation The post WATCH: Bayer pro…
Bayer agrees to US$7.25 billion proposed settlement over thousands of Roundup cancer lawsuits
Agrochemical maker Bayer and attorneys for cancer patients announced a proposed $7.25 billion settlement Tuesday to resolve thousands of U.S. lawsuits alleging the company failed to warn people that its popular weedkiller Roundup could cause cancer.
Pressed by thousands of judicial proceedings related to herbicide Roundup, the German company Bayer has advanced with a proposal for a global agreement of $7.25 billion (€6.12 billion to the current exchange) to compensate for alleged damages
Coverage Details
Bias Distribution
- 60% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
